This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.31 Firm Fixed Price Delivery Order is for the supply of Febuxostat 40 mg Tablets, a medication used to treat gout. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,021.11 firm fixed-price delivery order is for the supply of 4,566,211,033 tablets of febuxostat 40 mg, a medication used to treat gout. The contract has an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,481.02 firm fixed-price delivery order is for the supply of febuxostat 80 mg tablets, a medication used to treat gout. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,158.35, is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at...
The federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.73, is a Firm Fixed Price Delivery Order for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,904.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of febuxostat 40 mg tablets, a medication used to treat gout. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as the primary...
This federal contract award, valued at $2,317.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves...
This federal contract award, valued at $1,254.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Febuxostat 80 mg tablets, a medication used to treat gout. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,798.85 firm-fixed-price delivery order is for the supply of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,253.01 Firm Fixed Price Delivery Order contract is for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...